LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
448
via finance.yahoo.comBusiness & Companies

Merck ends nemtabrutinib development after the BELLWAVE program

FROM THE WIRE · FINANCE.YAHOO.COM

Merck MRK has made considerable progress in advancing the pipeline, particularly in areas like oncology, vaccines and infectious diseases, where it is developing several candidates with the potential to diversify the portfolio and expand the revenue base. MRK's phase III…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishDiscontinuing a hematology program is a negative step, though limited in scope for the group.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Merck announced the discontinuation of the BELLWAVE clinical program on nemtabrutinib (MK-1026).
  2. 02Nemtabrutinib is an investigational oral non-covalent Bruton's tyrosine kinase inhibitor.
  3. 03The drug was being developed for chronic lymphocytic leukemia and other lymphomas.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.